Clinical Trial Update: An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing SABER-Bupivacaine for postoperative pain control in hysterectomy patients has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• SABER®-Bupivacaine (bupivacaine)

Snippet

Sponsor: Durect | Conditions: Postoperative Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-06-01